Emerging Roles for Eosinophils in the Tumor Microenvironment (Q38662897)

5 September 2017

title

Emerging Roles for Eosinophils in the Tumor Microenvironment (English)

1 reference

5 September 2017

3

Ariel Munitz

1 reference

5 September 2017

2

Danielle Karo-Atar

1 reference

5 September 2017

1

Hadar Reichman

1 reference

5 September 2017

publication date

1 November 2016

1 reference

5 September 2017

1 reference

5 September 2017

volume

2

1 reference

5 September 2017

issue

11

1 reference

5 September 2017

page(s)

664-675

1 reference

Hallmarks of Cancer: The Next Generation

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophilic granulocytes and damage-associated molecular pattern molecules (DAMPs): role in the inflammatory response within tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils: changing perspectives in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils secrete IL-4 to facilitate liver regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

The transcription factor XBP1 is selectively required for eosinophil differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

IFN consensus sequence binding protein (Icsbp) is critical for eosinophil development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophilia in transgenic mice expressing interleukin 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Enterocyte expression of the eotaxin and interleukin-5 transgenes induces compartmentalized dysregulation of eosinophil trafficking.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

The potential of biologics for the treatment of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

A review of treatment with mepolizumab, an anti-IL-5 mAb, in hypereosinophilic syndromes and asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti–IL-5 antibody SCH55700

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

SIRPα/CD172a regulates eosinophil homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Inhibitory receptors on myeloid cells: new targets for therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils: 'new' roles for 'old' cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

CD300f associates with IL-4 receptor α and amplifies IL-4-induced immune cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

7 January 2021

Eosinophils and cancer.

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Pivotal Advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

The Importance of the Eosinophil in Head and Neck Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Involvement of eosinophils in the anti-tumor response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils in health and disease: the LIAR hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Alternatively activated dendritic cells regulate CD4 T-cell polarization in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophil Function in Eosinophil-associated Gastrointestinal Disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Gastrointestinal eosinophils in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils in Colorectal Neoplasms Associated with Expression of CCL11 and CCL24

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eotaxin expression in oral squamous cell carcinomas with and without tumour associated tissue eosinophilia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

The central role of CD4( ) T cells in the antitumor immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Physiologic concentrations of HMGB1 have no impact on cytokine-mediated eosinophil survival or chemotaxis in response to Eotaxin-2 (CCL24).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10-producing T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Regulation of allergic inflammatory responses by inhibitory receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Mechanisms of eosinophil-associated inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophil- and eosinophil granule-mediated pneumocyte injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Cytotoxic properties of eosinophil granule major basic protein for tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Human eosinophils exert TNF-α and granzyme A-mediated tumoricidal activity toward colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

IL-18 Is Involved in Eosinophil-Mediated Tumoricidal Activity against a Colon Carcinoma Cell Line by Upregulating LFA-1 and ICAM-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

2B4 (CD244) is expressed and functional on human eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Murine interleukin-4 displays potent anti-tumor activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

A critical role for eosinophils in allergic airways remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Identification of Innate IL-5–Producing Cells and Their Role in Lung Eosinophil Regulation and Antitumor Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8( ) T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils from hematopoietic stem cell recipients suppress allogeneic T cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Tumor-associated eosinophilia in interleukin-2-treated patients: evidence of toxic eosinophil degranulation on bladder cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Remodeling and fibrosis in chronic eosinophil inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Gastrointestinal eosinophils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

The Relationship Between Allergen-Induced Tissue Eosinophilia and Markers of Repair and Remodeling in Human Atopic Skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Expression of Vascular Endothelial Growth Factor by Human Eosinophils: Upregulation by Granulocyte Macrophage Colony-stimulating Factor and Interleukin-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

The role of eosinophil major basic protein in angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Differential macrophage programming in the tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

TNF Counterbalances the Emergence of M2 Tumor Macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Resistin-like molecule-α regulates IL-13-induced chemokine production but not allergen-induced airway responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Macrophages in Tissue Repair, Regeneration, and Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophils and oral squamous cell carcinoma: a short review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Eosinophil ablation and tumor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

The blockade of immune checkpoints in cancer immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

The role of myeloid cells in the promotion of tumour angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Tumor-associated macrophages: from mechanisms to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Mepolizumab and exacerbations of refractory eosinophilic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Treatment of patients with the hypereosinophilic syndrome with mepolizumab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

Re-defining the unique roles for eosinophils in allergic respiratory inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRECAN.2016.10.002

10.1016/J.TRECAN.2016.10.002

7 January 2021

Identifiers

DOI

1 reference

5 September 2017

1 reference